172 related articles for article (PubMed ID: 36618762)
41. Pulmonary function changes following helical tomotherapy in patients with inoperable, locally advanced non-small cell lung cancer.
Vekens K; Verbanck S; Collen C; Storme G; Barbé K; De Ridder M; Vanderhelst E
Strahlenther Onkol; 2020 Feb; 196(2):142-150. PubMed ID: 31300831
[TBL] [Abstract][Full Text] [Related]
42. Correlation of Functional Lung Heterogeneity and Dosimetry to Radiation Pneumonitis using Perfusion SPECT/CT and FDG PET/CT Imaging.
Lee HJ; Zeng J; Vesselle HJ; Patel SA; Rengan R; Bowen SR
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1255-1264. PubMed ID: 30108002
[TBL] [Abstract][Full Text] [Related]
43. Metrics of dose to highly ventilated lung are predictive of radiation-induced pneumonitis in lung cancer patients.
Flakus MJ; Kent SP; Wallat EM; Wuschner AE; Tennant E; Yadav P; Burr A; Yu M; Christensen GE; Reinhardt JM; Bayouth JE; Baschnagel AM
Radiother Oncol; 2023 May; 182():109553. PubMed ID: 36813178
[TBL] [Abstract][Full Text] [Related]
44. Poor baseline pulmonary function may not increase the risk of radiation-induced lung toxicity.
Wang J; Cao J; Yuan S; Ji W; Arenberg D; Dai J; Stanton P; Tatro D; Ten Haken RK; Wang L; Kong FM
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):798-804. PubMed ID: 22836048
[TBL] [Abstract][Full Text] [Related]
45. Four-dimensional computed tomography-based ventilation imaging in intensity-modulated radiation therapy treatment planning for pulmonary functional avoidance.
Iqbal GMD; Zhang H; D'Souza W; Ha L; Rosenberger JM
J Appl Clin Med Phys; 2023 Jun; 24(6):e13920. PubMed ID: 36727606
[TBL] [Abstract][Full Text] [Related]
46. A novel lung-avoidance planning strategy based on 4DCT ventilation imaging and CT density characteristics for stage III non-small-cell lung cancer patients.
Feng A; Shao Y; Wang H; Chen H; Gu H; Duan Y; Gan W; Xu Z
Strahlenther Onkol; 2021 Dec; 197(12):1084-1092. PubMed ID: 34351454
[TBL] [Abstract][Full Text] [Related]
47. Severity of radiation pneumonitis, from clinical, dosimetric and biological features: a pilot study.
Aso S; Navarro-Martin A; Castillo R; Padrones S; Castillo E; Montes A; Martínez JI; Cubero N; López R; Rodríguez L; Palmero R; Manresa F; Guerrero T; Molina M
Radiat Oncol; 2020 Oct; 15(1):246. PubMed ID: 33109238
[TBL] [Abstract][Full Text] [Related]
48. Pulmonary Function Changes After Radiotherapy for Lung or Esophageal Cancer: A Systematic Review Focusing on Dose-Volume Parameters.
Niezink AGH; de Jong RA; Muijs CT; Langendijk JA; Widder J
Oncologist; 2017 Oct; 22(10):1257-1264. PubMed ID: 28550029
[TBL] [Abstract][Full Text] [Related]
49. Changes in pulmonary function and their correlation with dose-volume parameters in patients undergoing stereotactic body radiotherapy for lung cancer.
Takemoto S; Shibamoto Y; Hashizume C; Miyakawa A; Murai T; Yanagi T; Sugie C; Nagai A
J Radiat Res; 2021 Mar; 62(2):338-345. PubMed ID: 33480428
[TBL] [Abstract][Full Text] [Related]
50. The Role of Pulmonary Function Test for Pulmonary Arterial Hypertension in Patients with Connective Tissue Disease.
Xiong J; Li J; Huang Y; Yang F; Wu R
Dis Markers; 2022; 2022():6066291. PubMed ID: 36212174
[No Abstract] [Full Text] [Related]
51. Different diffusing capacity of the lung for carbon monoxide as predictors of respiratory morbidity.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2009 Aug; 88(2):405-10; discussion 410-1. PubMed ID: 19632384
[TBL] [Abstract][Full Text] [Related]
52. Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer.
Taylor MD; LaPar DJ; Isbell JM; Kozower BD; Lau CL; Jones DR
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):738-44; Discussion 744-6. PubMed ID: 24252944
[TBL] [Abstract][Full Text] [Related]
53. Assessing four-dimensional CT stress maps derived from patient-specific biomechanical models of the lung with pulmonary function test data in lung cancer patients.
Shiinoki T; Fujimoto K; Kawazoe Y; Yuasa Y; Kajima M; Manabe Y; Hirano T; Matsunaga K; Tanaka H
Br J Radiol; 2023 Sep; 96(1149):20221149. PubMed ID: 37393529
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of lung toxicity risk with computed tomography ventilation image for thoracic cancer patients.
Otsuka M; Monzen H; Matsumoto K; Tamura M; Inada M; Kadoya N; Nishimura Y
PLoS One; 2018; 13(10):e0204721. PubMed ID: 30281625
[TBL] [Abstract][Full Text] [Related]
55. Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stem-cell rescue.
Lind PA; Marks LB; Jamieson TA; Carter DL; Vredenburgh JJ; Folz RJ; Prosnitz LR
Cancer; 2002 Jun; 94(11):2821-9. PubMed ID: 12115368
[TBL] [Abstract][Full Text] [Related]
56. SU-E-T-247: Dose-Volummetrics in the Prediction of Pulmonary Function Changes after Radiotherapy in Patients with Non-Small Cell Lung Cancer.
Zhu S; Li Y; Liu Z; Cao Y; Qiu R; Su J
Med Phys; 2012 Jun; 39(6Part13):3760. PubMed ID: 28517323
[TBL] [Abstract][Full Text] [Related]
57. Radiation and immune checkpoint inhibitor-mediated pneumonitis risk stratification in patients with locally advanced non-small cell lung cancer: role of functional lung radiomics?
Thomas HMT; Hippe DS; Forouzannezhad P; Sasidharan BK; Kinahan PE; Miyaoka RS; Vesselle HJ; Rengan R; Zeng J; Bowen SR
Discov Oncol; 2022 Sep; 13(1):85. PubMed ID: 36048266
[TBL] [Abstract][Full Text] [Related]
58. A prospective study on lung toxicity in patients treated with gemcitabine and carboplatin: clinical, radiological and functional assessment.
Dimopoulou I; Efstathiou E; Samakovli A; Dafni U; Moulopoulos LA; Papadimitriou C; Lyberopoulos P; Kastritis E; Roussos C; Dimopoulos MA
Ann Oncol; 2004 Aug; 15(8):1250-5. PubMed ID: 15277266
[TBL] [Abstract][Full Text] [Related]
59. Evaluating Which Dose-Function Metrics Are Most Critical for Functional-Guided Radiation Therapy.
Faught AM; Yamamoto T; Castillo R; Castillo E; Zhang J; Miften M; Vinogradskiy Y
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):202-209. PubMed ID: 28816147
[TBL] [Abstract][Full Text] [Related]
60. Functional avoidance-based intensity modulated proton therapy with 4DCT derived ventilation imaging for lung cancer.
Dougherty JM; Castillo E; Castillo R; Faught AM; Pepin M; Park SS; Beltran CJ; Guerrero T; Grills I; Vinogradskiy Y
J Appl Clin Med Phys; 2021 Jul; 22(7):276-285. PubMed ID: 34159715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
